drugset / Trial / NCT01374282

Post Marketing Surveillance Study of Cuprimine

NCT01374282

Expanded access No longer available Merck Sharp & Dohme LLC

Summary

Cuprimine (penicillamine) was made available in the Philippines by the Sponsor under a Compassionate Special Permit issued by the Bureau of Food and Drugs. Physicians were able to request the drug for their patients from the Sponsor. A Clinical Study Report form was completed for each purchase of Cuprimine.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject penicillamine Unknown

Indications